Kentucky Retirement Systems lessened its holdings in The Clorox Company (NYSE:CLX – Free Report) by 1.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 8,512 shares of the company’s stock after selling 117 shares during the period. Kentucky Retirement Systems’ holdings in Clorox were worth $1,382,000 at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. Catalyst Capital Advisors LLC purchased a new stake in shares of Clorox in the 3rd quarter worth approximately $54,000. Los Angeles Capital Management LLC raised its stake in shares of Clorox by 5.6% during the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock worth $31,266,000 after acquiring an additional 10,149 shares in the last quarter. Advisors Asset Management Inc. raised its stake in shares of Clorox by 43.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock worth $4,865,000 after acquiring an additional 9,037 shares in the last quarter. Natixis Advisors LLC raised its stake in shares of Clorox by 8.3% during the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock worth $10,341,000 after acquiring an additional 4,839 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Clorox by 1.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock worth $117,932,000 after acquiring an additional 13,038 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Clorox Stock Performance
Shares of CLX opened at $157.41 on Monday. The company has a 50-day simple moving average of $157.72 and a 200-day simple moving average of $159.96. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The company has a market capitalization of $19.39 billion, a PE ratio of 43.01, a P/E/G ratio of 2.62 and a beta of 0.42. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on CLX shares. Barclays upped their price target on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Evercore ISI increased their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Wells Fargo & Company increased their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and increased their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $158.21.
Check Out Our Latest Analysis on CLX
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- Health Care Stocks Explained: Why You Might Want to Invest
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- 3 Warren Buffett Stocks to Buy Now
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.